Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 01, 2017
- Source ID
- 10.1016/j.bbmt.2017.04.017
Entities
People
- Adriana K. Malone
- Amer Beitinjaneh
- Amir Steinberg
- Andrew C. Dietz
- Anne Warwick
- Bipin N Savani
- Bronwen E Shaw
- Christine Duncan
- Christopher Dandoy
- David Buchbinder
- David I. Marks
- Eric Chow
- Görgün Akpek
- Heather R. Millard
- Hillard M Lazarus
- K. Scott Baker
- Kimberly A. Kasow
- Lisa Diller
- Lolie C. Yu
- Lynda M. Vrooman
- Mahmoud Aljurf
- Mary E. Flowers
- Menachem Bitan
- Minoo Battiwalla
- Morris Kletzel
- Navneet S Majhail
- Olle Ringden
- Peiman Hematti
- Rajinder Bajwa
- Rammurti T. Kamble
- Richard F. Olsson
- Robert J. Hayashi
- Robert Peter Gale
- Ruta Brazauskas
- Sachiko Seo
- Shahrukh K Hashmi
- Tracey A. O'brien
Organizations
- Actinium Pharmaceuticals (United States)
- Alexion Pharmaceuticals
- Amgen
- Astellas Pharma (United States)
- AstraZeneca
- AstraZeneca (United States)
- Atara Biotherapeutics, Inc.
- Bristol-Myers Squibb
- Celgene
- Chiron Corporation
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- Genzyme
- Gilead Sciences
- Health Resources and Services Administration
- HistoGenetics (United States)
- Incyte
- Janssen Scientific Affairs (United States)
- Jazz Pharmaceuticals
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Otsuka (United States)
- Otsuka Pharmaceutical
- Patient-Centered Outcomes Research Institute
- Pfizer
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Spectrum Pharmaceuticals
- St. Baldrick's Foundation
- Swedish Orphan Biovitrum
- Takeda Oncology
- University of Minnesota